MyMD Pharmaceuticals Inc (MYMD)

[Twice Worthy]

Dosing completed with Sarcopenia cohorts in the blinded study of MYMD-1 drug. FDA's Safety Committee will be reviewing the results of the blinded study. The results will be shared with MYMD once completed and, the company would then post the results from the study. The results from the study could be very significant and could begin to propel MYMD stock higher based on the new drug's effect with patients. The study results should be posted in a few weeks ... very much looking forward to them and the effect on MYMD's share price.

[Twice Worthy]

MYMD submitted details for a NDA (new drug application) to the FDA. MYMD is awaiting a response from the FDA on the details before submitting their proposal for their NDA. The thought is that the FDA should respond by July to MYMD re: the NDA details. I was expecting an announcement earlier, by the end of May but, there was none. So I called the company to inquire. The above communication was what I was told and was sharing. I believe the steps MYMD and Chris Chapman are taking on the new NDA drug study could produce a monumental response. Let us not forget all the significant fiduciaries that got involved in MYMD last year and ended up driving the MYMD share price above $5 and $6 a share.

I am a big believer in MYMD !!!!!

[surf1944]

https://stockcharts.com/h-sc/ui?s=MYMD&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/MYMD/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/MYMD/opinion

[Twice Worthy]

Potential news still pushing the stock higher 11 days later after my last post ... already cleared it's inverted 50dma ... head upwards to overtake it's inverted 200dma, currently sitting at $2.27 ... MYMD Relative Strength continuing to move UP robustly inn pursuit at 62.21.

[Twice Worthy]

In After Hours saw the stock trade UP to $1.94 ... UP 15% from Friday's closing price on excellent volume and cleared it's inverted 50 DMA. "Upcoming highlights include a planned filing of an investigational New Drug application (IND) with the FDA by the end of the month, with recruitment, enrollment, and dosing commencing next quarter." This potential news may have pushed the stock UP today.

[Twice Worthy]

Currently in Phase ! ... Phase 2 commencing in July ... dosing trials with cohorts almost complete ... the FDA's Safety Committee monitoring the patients on the new drug has already noted that there were no toxicity issues with the drug thus far. Company evaluating which dose is the most effective.

[idcc2006]

does isomyosmine (or anatabine) alleviate autoimmune symptoms?

[leifsmith]

New Jonnie R. Williams Patent, "Cannabinoid Compounds"

Issue Date: 4/18/23
Inventor Name: Jonnie R. Williams
Organization Name: MyMD Pharmaceuticals (Florida), Inc.
Title: Synthetic Cannabinoid Compounds for Treatment of Substance Addiction and Other Disorders

https://patentcenter.uspto.gov/applications/17383119/ifw/docs

See document "Application Data Sheet" dated 07/22/2021 for details of original filing.

Conjecture: Williams (totally without credentials) is one of the world's most important biochemists. -- to be refuted in time, or not. (See Conjectures and Refutations, by Karl R. Popper)

[SeanVan]

That means, Cohort 4 takes atleast 4 weeks ( 28 days) to complete plus Data submission time Plus FDA approval time.... Totaling over another 3 months...

[leifsmith]

Looks to me like cohorts 1,2,3 are done, and a boost of dose is still ahead for cohort 4.

[SeanVan]

confused with this PR, as it says: - MyMD is only 3 patients away from dosing its final patient in its first Phase 2 clinical trial of lead drug candidate MYMD-1® - on Top...
.
But in the second paragraph of the PR, it says : To date, three subjects from Cohort 4 have completed end of study visits. There are no outstanding study visits and all 30 patients have officially completed all study parameters and been discharged from the study.

Can you please clarify this.
TY

[leifsmith]

PR this morning

https://ir.mymd.com/news-events/press-releases/detail/49/mymd-pharmaceuticals-provides-dosing-update-on-phase-2

[sheepsandgoats]

I believe, after reading the annual report, they decided on a private placement, which they completed, for a bit over $30M in cash. They simply restructured the deal, and tabled other voting items for a later date. That's my read.

[SeanVan]

It seems that most of the share holders Voted against their proposals.
I'm sure everyone is very disappointed about their fake manipulation of Stock price on the date of Good news..

[Monroe1]

Any thoughts on this cancelation?
https://archive.fast-edgar.com/20230322/AS2ZB22CZ22RPJRZ2K2B2ZY2PLW9ZZ22ZV52/

[sheepsandgoats]

Any idea why the drop between 1:00 PM and 2:00? Just reading the chart, looks like an institutional level spook?

[SeanVan]

The investor in none other than Johnnie's family & Trusts. He is the founder and he further invested in it. SO far, all I can see is , all manipulation and greediness.

[leifsmith]

Ray Blanco, on 23 Feb 2023 told readers that the $15 million raise is a positive signal because it shows that current large investors have confidence in the company's progress and prospects.

[decolla15]

https://www.businesswire.com/news/home/20230221005277/en/

[sheepsandgoats]

Thanks for posts. Both make sense, but the naked short selling makes the most sense. This implicates the usual NASDAQ players, and the brokerages supporting market makers. While Williams may be using these market makers given the enormous slice of shares he owns, I find it hard to believe his leadership team would be willing to tolerate and even participate in NSS, as this could create red flags for FDA.

It takes a lot of guts for many of you to stay committed to a stock in this position. Cheers to you. Be safe.

[B and B]

Naked short selling

[B and B]

Test

[SeanVan]

There is no news, and Its a pure manipulation by secondary brokerages that control MyMD stock on day to day basis. 70% of ownership belong to the owner of MyMD (Johnnie Williams) and remaining 30% belong to old AKers shares plus all public ownership.

[sheepsandgoats]

Anyone know who is manipulating the stock right into a Feb 17 2013 2.50 "sweet spot" (for calls and puts) for the house? Jumping 75 cents in less than 72 hours before expiration with no news to speak and a single buy of over 50K shares at close today? Timing is suspicious. Is this notorious NASDAQ manipulation, or secondary brokerages lending shares for shorts and marking as "buy?" Something else?

[leifsmith]

I think Ray was calling his own communication an "update". As in "I'm updating my readers on what I'm thinking now."

[SeanVan]

Old news: About MyMD by Ray Blanco.

https://www.stockgumshoe.com/reviews/ray-blancos-catalyst-trader/de-tease-ray-blanco-and-james-altuchers-sub-5-arthritis-stock/

[sheepsandgoats]

Was the update you received recently the one Blanco announced was coming re: MYMD? If so, doesn't seem like an update, but rather a hook for recent converts.

[sheepsandgoats]

I can't help but hope for the short sellers to get burned with huge margin calls and we can shake that dirt off this stock!

[BioFan1]

Lift off in progress.
The MYMD science is out there for all to see, and those who understand it are all in. There is no drug that has this much potential to treat so many diseases. Stocks like this can go from $2.60 to $95.00 in a year or less. Witness AXSM, which does not have a fraction of MYMD’s potential.

[leifsmith]

Just got Ray Blanco's email: "An Important Update About Our Miracle Drug Play". Came in at about 10:30 ET.

Says the new drug could prove revolutionary, and that huge catalysts [to stock price, I assume] will come in the near future

Blanco's email covers the science already familiar to participants in this board, and earlier boards covering Star Scientific and Anatabloc.

Although MYMD-1 is not anatabine citrate (Star Scientific), its functions are similar, and it is being developed by some of the same scientists, behind whom stands Jonnie Williams.

For that science see https://www.mymd.com

[deast]

Ray Blanco emailed yesterday that an update is coming today re MyMD.

[leifsmith]

I watch Ray Blanco and have seen nothing from him about MyMD recently. But if I've missed something please post about it. Thanks.

[B and B]

test

[B and B]

Ray Blanco pounding the tables over the weekend is my guess

[Huntewr7]

Looking much Better. News must be on the way.

[leifsmith]

Anyone know anything about what's causing the sudden increase in price and volume?

[deast]

This must be the best kept secret since the Manhattan Project. Management may be translating the promised 4th quarter news into a dialect only spoken in a remote region of Tibet. Here's hoping that the followers of this company increases 100 fold next week. Happy Holidays!

[deast]

I wish they would hire a person with real time experience to run this company. Academics and money people run this company and that speaks volumes. Hope they make some changes.

[SeanVan]

It seems, the management discouraging the public to buy stocks by reducing the stock price for no reason. Something is not correct.

[leifsmith]

Rivard Paul (EVP of Operations, GC) Buys 10,000 @ Avg Price: $1.53

https://www.benzinga.com/secfilings/22/12/30016914/mymd-pharmaceuticals-inc-rivard-paul-evp-of-operations-gc-buys-10-000-avg-price-1-53-form4

[leifsmith]

6 Dec 2022 News Release

https://www.businesswire.com/news/home/20221206005205/en/

Two important things (of many):

1) Selective inhibition of TNF-alpha
2) Oral administration

The reduction of inflammation compared to a widely prescribed biologic may not be as great as some had hoped.

What the NR does not cover is the harm not done by MYMD-1 compared to the (and all similar) biologic.

"Harm Not Done" should become a major selling point.

MYMD-1 is a jeweler's hammer, harmlessly doing only what's needed; Currently prescribed biologics are a wrecking ball, doing what's needed, but also doing a lot that's harmful.

[deast]

Amazing that the current management cannot write a simple effective press release.

[leifsmith]

The latest news: Conservative language reports results of significance which are poorly understood. Stronger sales language would boost the stock price. I'm happy to wait.

[SeanVan]

Today's News (12-06-2022)
https://www.businesswire.com/news/home/20221206005205/en/

[mrboom]

They only finished 2 cohorts. Where did you see 99.9 percent results?

[SeanVan]

So far, 2 groups were successful with 99.9% positive results, and 3rd group ( cohort of 40 people) plus final comparison study might have been completed by now. They might be uploading results.
We might see the news of Phase-2 completion in a month or so, before Xmas.

[leifsmith]

I don't see anything in that news release that limits the positive results to "one group". Please clarify. Thanks.

[mrboom]

It says worked in one dose group. Wonder which one ?

[mrboom]

When is the stock going to turn? Goes down almost everyday

[upstater]

Beware. If you order Anatabloc (brand name) from Pick Vitamin, you only get 1 bottle, not 2. I may check out Predator. They did give me a bottle of Omega 3 as a gift, but it was small consolation.